Ikarian Capital, LLC Aadi Bioscience, Inc. Transaction History

Ikarian Capital, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	BUY	$11.57 - $17.92 $2.36 Million - $3.66 Million	203,975 Added 97.89%	412,343 $1.27 Million
Q1 2022 May 13, 2022	BUY	$16.65 - $24.97 $199,133 - $298,641	11,960 Added 6.09%	208,368 $3.54 Million
Q4 2021 Feb 14, 2022	BUY	$19.32 - $29.02 $3.57 Million - $5.37 Million	185,000 Added 1621.67%	196,408 $4.74 Million
Q3 2021 Nov 15, 2021	BUY	$25.52 - $41.85 $291,132 - $477,424	11,408 New	11,408 $335,000

15.6M

15K

3.1K

Ticker AADI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 21,016,800
Market Cap $40.1M
Description
Aadi Bioscience, Inc., a clinical-stage biopharmaceutical company, engages in developing and commercializing precision therapies for genetically defined cancers with alterations in mTOR pathway genes. Its lead drug candidate, FYARRO is a form of sirolimus bound to albumin. Aadi is evaluating FYARRO in cancers with known mTOR pathway activation, ...

Get notified when there are updates to the investment portfolio of Ikarian Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Ikarian Capital, LLC with notifications on news.